tiprankstipranks

Mark Leschly Insider Profile

4 Followers
Mark Leschly, Director at Anacor Pharmaceuticals, holds 593.68K shares in ChargePoint Holdings (Ticker: CHPT), holds 3.77M shares in NGM Biopharmaceuticals (Ticker: NGM), holds 794.00 shares in Anacor Pharmaceuticals (Ticker: ~ANAC).
tipranks
Mark Leschly

Mark Leschly
Anacor Pharmaceuticals (~ANAC)
Director

Not Ranked
Mark Leschly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Mark Leschly's holdings

Insider Roles

ChargePoint Holdings
(CHPT)
Director
Roles that Mark Leschly holds in companies

Most Profitable Insider Trade

Stock:
Anacor Pharmaceuticals
(~ANAC)
Rating:Informative Sell
Date:Aug 29, 2014 - Aug 29, 2015
Return:-481.50%
The most profitable trade made by Mark Leschly

Mark Leschly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ANAC
Anacor Pharmaceuticals
Jun 24, 2016
Uninformative Sell
78.80K
$78.67K
NGM
NGM Biopharmaceuticals
Apr 10, 2019
Uninformative Buy
$5.80M
ChargePoint Holdings
Jul 11, 2024
Director
Uninformative Buy
$1.16M
SNMX
Senomyx
$41.79K
List of latest transactions for each holding click on a transaction to see Mark Leschly's performance on stock

Mark Leschly insider profile FAQ

What is the percentage of profitable transactions made by Mark Leschly?
The percentage of profitable transactions made by Mark Leschly is ―.
    What is the average return per transaction made by Mark Leschly?
    The average return per transaction made by Mark Leschly is ―.
      What stocks does Mark Leschly hold?
      Mark Leschly holds: ~ANAC, NGM, CHPT, SNMX stocks.
        What was Mark Leschly’s latest transaction?
        Mark Leschly latest transaction was an Uninformative Buy of ―.
          What was Mark Leschly's most profitable transaction?
          Mark Leschly’s most profitable transaction was an Informative Sell of ~ANAC stock on August 29, 2014. The return on the trade was -481.50%.
            What is Mark Leschly's role in Anacor Pharmaceuticals?
            Mark Leschly's role in Anacor Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.